IE33924B1 - 11beta -chloro-19-nor-steroids - Google Patents
11beta -chloro-19-nor-steroidsInfo
- Publication number
- IE33924B1 IE33924B1 IE105/69A IE10569A IE33924B1 IE 33924 B1 IE33924 B1 IE 33924B1 IE 105/69 A IE105/69 A IE 105/69A IE 10569 A IE10569 A IE 10569A IE 33924 B1 IE33924 B1 IE 33924B1
- Authority
- IE
- Ireland
- Prior art keywords
- pyrazolino
- steroids
- chloro
- activity
- methylene
- Prior art date
Links
- 239000000203 mixture Substances 0.000 abstract 3
- 230000003054 hormonal effect Effects 0.000 abstract 2
- -1 16, 17-methylene Chemical group 0.000 abstract 1
- 239000004593 Epoxy Substances 0.000 abstract 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 230000002280 anti-androgenic effect Effects 0.000 abstract 1
- 230000001833 anti-estrogenic effect Effects 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940124558 contraceptive agent Drugs 0.000 abstract 1
- 239000003433 contraceptive agent Substances 0.000 abstract 1
- 125000003700 epoxy group Chemical group 0.000 abstract 1
- 229940011871 estrogen Drugs 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 229960002568 ethinylestradiol Drugs 0.000 abstract 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
- 239000007935 oral tablet Substances 0.000 abstract 1
- 230000001072 progestational effect Effects 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/0025—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
- C07J7/0035—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a hydroxy group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
- C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0057—Nitrogen and oxygen
- C07J71/0068—Nitrogen and oxygen at position 16(17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
- C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
- C07J73/003—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4570/68A GB1260465A (en) | 1968-01-29 | 1968-01-29 | 11beta-CHLORO-19-NOR-STEROIDS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE33924L IE33924L (en) | 1969-07-29 |
| IE33924B1 true IE33924B1 (en) | 1974-12-11 |
Family
ID=9779640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE105/69A IE33924B1 (en) | 1968-01-29 | 1969-01-27 | 11beta -chloro-19-nor-steroids |
Country Status (14)
| Country | Link |
|---|---|
| JP (2) | JPS4828907B1 (en, 2012) |
| AT (1) | AT309703B (en, 2012) |
| BE (1) | BE727578A (en, 2012) |
| BR (1) | BR6905985D0 (en, 2012) |
| CH (2) | CH578017A5 (en, 2012) |
| DE (1) | DE1904325C3 (en, 2012) |
| DK (1) | DK128715B (en, 2012) |
| ES (1) | ES363068A1 (en, 2012) |
| FR (1) | FR2000924A1 (en, 2012) |
| GB (1) | GB1260465A (en, 2012) |
| IE (1) | IE33924B1 (en, 2012) |
| IL (1) | IL31515A0 (en, 2012) |
| NL (1) | NL6901342A (en, 2012) |
| SE (2) | SE386903B (en, 2012) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS52119945U (en, 2012) * | 1976-03-08 | 1977-09-12 | ||
| US5710293A (en) * | 1995-10-13 | 1998-01-20 | The Population Council, Center For Biomedical Research | Method of preparation of ester derivatives of steroids |
-
1968
- 1968-01-29 GB GB4570/68A patent/GB1260465A/en not_active Expired
-
1969
- 1969-01-27 IE IE105/69A patent/IE33924B1/xx unknown
- 1969-01-28 NL NL6901342A patent/NL6901342A/xx not_active Application Discontinuation
- 1969-01-29 BE BE727578D patent/BE727578A/xx unknown
- 1969-01-29 BR BR205985/69A patent/BR6905985D0/pt unknown
- 1969-01-29 SE SE7208742A patent/SE386903B/xx unknown
- 1969-01-29 AT AT91269A patent/AT309703B/de not_active IP Right Cessation
- 1969-01-29 FR FR6901753A patent/FR2000924A1/fr not_active Withdrawn
- 1969-01-29 DE DE1904325A patent/DE1904325C3/de not_active Expired
- 1969-01-29 DK DK46569AA patent/DK128715B/da unknown
- 1969-01-29 CH CH138669A patent/CH578017A5/xx not_active IP Right Cessation
- 1969-01-29 SE SE01193/69A patent/SE364267B/xx unknown
- 1969-01-29 ES ES363068A patent/ES363068A1/es not_active Expired
- 1969-01-29 CH CH45972A patent/CH592688A5/xx not_active IP Right Cessation
- 1969-01-29 JP JP44006062A patent/JPS4828907B1/ja active Pending
- 1969-01-30 IL IL31515A patent/IL31515A0/xx unknown
-
1971
- 1971-10-11 JP JP46079507A patent/JPS4830051B1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AT309703B (de) | 1973-08-27 |
| BR6905985D0 (pt) | 1973-04-19 |
| CH592688A5 (en, 2012) | 1977-11-15 |
| GB1260465A (en) | 1972-01-19 |
| DE1904325B2 (de) | 1978-02-16 |
| ES363068A1 (es) | 1971-06-16 |
| CH578017A5 (en, 2012) | 1976-07-30 |
| IE33924L (en) | 1969-07-29 |
| SE364267B (en, 2012) | 1974-02-18 |
| JPS4828907B1 (en, 2012) | 1973-09-05 |
| FR2000924A1 (en, 2012) | 1969-09-19 |
| DK128715B (da) | 1974-06-24 |
| DE1904325C3 (de) | 1978-10-26 |
| IL31515A0 (en) | 1969-03-27 |
| NL6901342A (en, 2012) | 1969-07-31 |
| SE386903B (sv) | 1976-08-23 |
| JPS4830051B1 (en, 2012) | 1973-09-17 |
| DE1904325A1 (de) | 1969-09-04 |
| BE727578A (en, 2012) | 1969-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1163737A (en) | Improvements in or relating to 7-Dihalomethyl Steroids | |
| IL45200A (en) | 16 ,17 -cyclopentylidenedioxy-9 -fluoro-11 ,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate and anti-inflammatory compositions comprising it | |
| GB1291205A (en) | A novel pregnane derivative, processes for its preparation, and compositions incorporating it | |
| IE33924L (en) | 11beta-chloro-19-nor-steroids | |
| Dorfman et al. | Uterotrophic activity of various phenolic steroids | |
| GB1508745A (en) | Steroidal(16alpha,17-d)cyclohexenes | |
| IL49132A0 (en) | New steroids of the androstane series,their preparation and pharmaceutical compositions containing them | |
| IE34308B1 (en) | 11beta,13beta dialkylgona-1,3,5(10)-trien-3-ol 3-cycloalkyl ethers | |
| PH12178A (en) | 11-substituted steroids of the estrane series and pharmaceutical composition thereof | |
| PH18164A (en) | New 11-hydroxy steroids of the pregnane series substituted in the 17-position and their pharmaceutical compositions | |
| AU472706B2 (en) | Anaesthetic steroid compositions | |
| Dorfman et al. | The assay of orally administered androgens using the chick's comb | |
| Swyer | Progestogens and their clinical uses: Part I | |
| GB1323383A (en) | Pregna-4,9-diene processes for its preparation and compositions thereof | |
| FI793027A7 (fi) | Uusia androstaani-, estraani- ja pregnaani-sarjan 3 -amino-2 -hydroksi-steroideja, menetelmiä niiden vavalmistamiseksi sekä farmaseuttisia yhdistelmiä. | |
| IL32901A (en) | Glycosidyl and glycuronosidyl steroids of the estrane series,preparation thereof and use as estrogenic agents | |
| GB1260463A (en) | 11beta-BROMO-19-NOR-STEROIDS | |
| GB1116795A (en) | An oral contraceptive preparation | |
| IL36654A0 (en) | New oestrogenically highly active steroids of the estrane series,their manufacture and pharmaceutical compositions containing them | |
| AU247661B2 (en) | Steroid compounds for use in the synthesis of 9 a-fluoro-1 b, 17 a, 21-trihydroxy-16 a-methyl-pregna-1, 4-dien-3, 20-dione, processes for preparation thereof and for their conversion | |
| IL36653A0 (en) | A new highly active oestrogenic steroid of the estrane series,its manufacture and pharmaceutical compositions containing it | |
| AU5631060A (en) | Steroid compounds for use in the synthesis of 9 a-fluoro-1 b, 17 a, 21-trihydroxy-16 a-methyl-pregna-1, 4-dien-3, 20-dione, processes for preparation thereof and for their conversion | |
| GB1285263A (en) | IMPROVEMENTS IN OR RELATING TO 6alpha,6beta-DIFLUORO STEROIDS | |
| GB1313659A (en) | 9alpha-unsubstituted-11beta-chloro-19-norpregnane compounds | |
| GB1087585A (en) | Improvements in or relating to tetrahydropyranylethers of steroids |